Bionano Genomics, Inc. (BNGO)
NASDAQ: BNGO · Real-Time Price · USD
4.000
-0.130 (-3.15%)
At close: Aug 22, 2025, 4:00 PM
4.020
+0.020 (0.50%)
After-hours: Aug 22, 2025, 7:59 PM EDT
Bionano Genomics Stock Forecast
Stock Price Forecast
The 3 analysts that cover Bionano Genomics stock have a consensus rating of "Buy" and an average price target of $7.67, which forecasts a 91.75% increase in the stock price over the next year. The lowest target is $4.00 and the highest is $11.
Price Target: $7.67 (+91.75%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Bionano Genomics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 1 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 4 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $10 → $11 | Strong Buy | Maintains | $10 → $11 | +175.00% | Aug 18, 2025 |
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades $8 | Hold → Strong Buy | Upgrades | $8 | +100.00% | May 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +150.00% | Apr 9, 2025 |
| Scotiabank | Scotiabank | Hold Maintains $1 → $4 | Hold | Maintains | $1 → $4 | n/a | Apr 2, 2025 |
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 15, 2024 |
Financial Forecast
Revenue This Year
30.69M
from 30.78M
Decreased by -0.28%
Revenue Next Year
35.46M
from 30.69M
Increased by 15.54%
EPS This Year
-7.39
from -88.13
EPS Next Year
-4.15
from -7.39
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 33.4M | 42.9M | 55.1M | ||
| Avg | 30.7M | 35.5M | 53.5M | ||
| Low | 27.0M | 30.4M | 51.4M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 8.7% | 39.8% | 55.4% | ||
| Avg | -0.3% | 15.5% | 50.9% | ||
| Low | -12.4% | -1.0% | 45.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -5.70 | -3.00 | -1.44 | ||
| Avg | -7.39 | -4.15 | -1.40 | ||
| Low | -10.05 | -5.13 | -1.34 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.